Navigating the complexities of the biopharmaceutical industry requires more than scientific insight; it demands rigorous decision analysis. Decision Analysis and Portfolio Management in the Biopharma Industry serves as an essential practitioner’s guide to managing the inherent risks and rewards of drug development. This book offers a structured approach to valuing R&D projects and constructing balanced portfolios that align with corporate strategy. By combining quantitative techniques with practical industry wisdom, the authors demystify the process of resource allocation, probability assessment, and strategic planning. Whether you are a scientist transitioning into management or an established leader, this guide equips you with the analytical tools needed to navigate the challenges of the modern biopharma landscape. You will learn to identify key value drivers, assess technical and commercial risks, and optimise your development pipeline to achieve long-term growth and success.